China Factory Supply API 99% Purity CAS 50-02-2 Dexame′ Thasone Powder, Find details about China 50-02-2, De Fla Za Cort from Factory Supply API 99% Purity CAS 50-02-2 Dexame′ Thasone Powder
Factory supply API 99% purity CAS 50-02-2 Dexa methasone powder
Product name | Dexam ethasone |
CAS No. | 50-02-2 |
Other Names | Dexam ethasone Base |
Molecular Formula | C22H29FO5 |
Molecular weight | 392.46 |
EINECS NO. | 200-003-9 |
Grade Standard | Medicine Grade |
COA | Available |
MOQ | 100g, 1KG |
Item | Specifications |
Appearance | White to off white powder. |
Purity | 99%min |
Melting point | 262-264ºC |
Specific rotation | 75 º (c=1, dio xane) |
Boiling point | 568.2±50.0ºC at 760 mmHg |
Density | 1.1283 (estimate) |
Refractive index | 76 ° (C=1, Dio xane) |
Flash point | 9 degree |
Solubility | ethanol: 1 mg/mL, H2O:10 mg/100 mL (25 ºC) |
Stability | Stable. Combustible. Incompatible with strong oxidizing agents, strong bases, acid anhydrides, acid chlorides. May be light sensitive. |
Storage condition | 2-8 degree |
Shelf life | 2 years |
Adrenocorticotropic hormone drugs, anti-inflammatory, anti-allergic and anti-drug more effective than pre dni sone, and promoting the removal of potassium sodium retention is very light, intramuscular or intravenous pituitary - adrenal strong inhibition:
- Anti-inflammatory effects: The product can reduce and prevent tissue response to inflammation, thereby reducing inflammation performance. Hormone suppression of inflammatory cells, including leukocytes and macrophages accumulation in sites of inflammation and inhibition of phagocytosis, lysosomal enzyme release and synthesis and release of inflammatory chemical mediators. Can reduce and prevent tissue response to inflammation, thereby reducing inflammation performance.
- Immunosuppressive effect: preventing or inhibiting cell-mediated immune response, delayed hypersensitivity reactions, reducing T lymphocytes, monocytes, eosinophils, reducing immunoglobulin binding to cell surface receptors and inhibition of the synthesis and release of interleukin, thus reducing the T lymphocyte transformation of lymphoblastoid cells, and reduce the extension of the primary immune response. Can reduce immune complexes through the basement membrane, and can reduce the concentration of ingredients complement and immunoglobulins.